Related references
Note: Only part of the references are listed.In Vitro Activities of Ceftazidime-Avibactam and Aztreonam-Avibactam against 372 Gram-Negative Bacilli Collected in 2011 and 2012 from 11 Teaching Hospitals in China
Xiaojuan Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from US Medical Centers in 2012
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Reclaiming the Efficacy of β-Lactam-β-Lactamase Inhibitor Combinations: Avibactam Restores the Susceptibility of CMY-2-Producing Escherichia coli to Ceftazidime
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance
S. D. Lahiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Bactericidal Activity, Absence of Serum Effect, and Time-Kill Kinetics of Ceftazidime-Avibactam against β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
Tiffany R. Keepers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Avibactam activity against extended-spectrum AmpC β-lactamases
Nerea Porres-Osante et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
David E. Ehmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Design and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-Lactamase
Marisa L. Winkler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Exploring the Role of a Conserved Class A Residue in the Ω-Loop of KPC-2 β-Lactamase A MECHANISM FOR CEFTAZIDIME HYDROLYSIS
Peter S. Levitt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Twelve Positions in a β-Lactamase That Can Expand Its Substrate Spectrum with a Single Amino Acid Substitution
Hyojeong Yi et al.
PLOS ONE (2012)
Ligand-Dependent Disorder of the Ω Loop Observed in Extended-Spectrum SHV-Type β-Lactamase
Jared M. Sampson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-Lactamase
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Updated Functional Classification of beta-Lactamases
Karen Bush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Substrate Selectivity and a Novel Role in Inhibitor Discrimination by Residue 237 in the KPC-2 β-Lactamase
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Extended-spectrum β-lactamase-producing organisms
M. E. Falagas et al.
JOURNAL OF HOSPITAL INFECTION (2009)
Genetic and Structural Characterization of an L201 P Global Suppressor Substitution in TEM-1 β-Lactamase
David C. Marciano et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Role of Asp104 in the SHV β-lactamase
Christopher R. Bethel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Rational design of a β-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate:: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone
Pius S. Padayatti et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
A novel ceftazidime-hydrolysing extended-spectrum β-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop
Il Kwon Bae et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Unexpected enzyme TEM-126: Role of mutation Asp179Glu
J Delmas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Novel SHV-derived-extended-spectrum β-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin
L Ma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A novel extended-spectrum β-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance
E Stürenburg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Inhibitor-resistant class A β-lactamases:: Consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant
T Sun et al.
BIOCHEMISTRY (2004)
A new TEM-derived extended-spectrum β-lactamase (TEM-91) with an R164C substitution at the Ω-loop confers ceftazidime resistance
H Kurokawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Unexpected advanced generation cephalosporinase activity of the M69F variant of SHV β-lactamase
MS Helfand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CTX-M-type extended-spectrum β-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
SHV-16, a β-lactamase with a pentapeptide duplication in the omega loop
C Arpin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
A new SHV-derived extended-spectrum β-lactamase (SHV-24) that hydrolyzes ceftazidime through a single-amino-acid substitution (D179G) in the Ω-loop
H Kurokawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
